These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 12599078
1. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S. J Infect Dis; 2003 Feb 15; 187(4):613-24. PubMed ID: 12599078 [Abstract] [Full Text] [Related]
2. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, Yagyu K, Muraoka A, Sugai M, Hiramatsu K, Honke K, Matsuzaki S. J Infect Dis; 2007 Oct 15; 196(8):1237-47. PubMed ID: 17955443 [Abstract] [Full Text] [Related]
3. Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity. Rashel M, Uchiyama J, Takemura I, Hoshiba H, Ujihara T, Takatsuji H, Honke K, Matsuzaki S. FEMS Microbiol Lett; 2008 Jul 15; 284(1):9-16. PubMed ID: 18462391 [Abstract] [Full Text] [Related]
4. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Sunagar R, Patil SA, Chandrakanth RK. Res Microbiol; 2010 Dec 15; 161(10):854-60. PubMed ID: 20868746 [Abstract] [Full Text] [Related]
5. Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential. Hoshiba H, Uchiyama J, Kato S, Ujihara T, Muraoka A, Daibata M, Wakiguchi H, Matsuzaki S. Arch Virol; 2010 Apr 15; 155(4):545-52. PubMed ID: 20224894 [Abstract] [Full Text] [Related]
6. Experimental phage therapy against Staphylococcus aureus in mice. Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. Antimicrob Agents Chemother; 2007 Aug 15; 51(8):2765-73. PubMed ID: 17517843 [Abstract] [Full Text] [Related]
7. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Wang J, Hu B, Xu M, Yan Q, Liu S, Zhu X, Sun Z, Reed E, Ding L, Gong J, Li QQ, Hu J. Int J Mol Med; 2006 Feb 15; 17(2):309-17. PubMed ID: 16391831 [Abstract] [Full Text] [Related]
8. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP. J Bacteriol; 2005 Oct 15; 187(20):7161-4. PubMed ID: 16199588 [Abstract] [Full Text] [Related]
9. The potential of phages to prevent MRSA infections. Mann NH. Res Microbiol; 2008 Jun 15; 159(5):400-5. PubMed ID: 18541414 [Abstract] [Full Text] [Related]
10. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Clin Infect Dis; 2003 Dec 01; 37(11):1453-60. PubMed ID: 14614667 [Abstract] [Full Text] [Related]
11. Helenalin reduces Staphylococcus aureus infection in vitro and in vivo. Boulanger D, Brouillette E, Jaspar F, Malouin F, Mainil J, Bureau F, Lekeux P. Vet Microbiol; 2007 Jan 31; 119(2-4):330-8. PubMed ID: 17010538 [Abstract] [Full Text] [Related]
12. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. Gu J, Xu W, Lei L, Huang J, Feng X, Sun C, Du C, Zuo J, Li Y, Du T, Li L, Han W. J Clin Microbiol; 2011 Jan 31; 49(1):111-7. PubMed ID: 21048011 [Abstract] [Full Text] [Related]
13. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Gupta R, Prasad Y. Curr Microbiol; 2011 Jan 31; 62(1):255-60. PubMed ID: 20607539 [Abstract] [Full Text] [Related]
14. Protective effects of synthetic antibacterial oligopeptides based on the insect defensins on Methicillin-resistant Staphylococcus aureus in mice. Saido-Sakanaka H, Ishibashi J, Momotani E, Yamakawa M. Dev Comp Immunol; 2005 Jan 31; 29(5):469-77. PubMed ID: 15707667 [Abstract] [Full Text] [Related]
15. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Rahman M, Kim S, Kim SM, Seol SY, Kim J. Biofouling; 2011 Nov 31; 27(10):1087-93. PubMed ID: 22050201 [Abstract] [Full Text] [Related]
17. [Combination utility of phages GH15 and K against Staphylococcus aureus]. Liu X, Gu J, Han W, Li Y, Han D, Zhang Q, Lu R, Song J, Feng X, Lei L. Wei Sheng Wu Xue Bao; 2013 May 04; 53(5):498-506. PubMed ID: 23957155 [Abstract] [Full Text] [Related]
18. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. Kokai-Kun JF, Chanturiya T, Mond JJ. J Antimicrob Chemother; 2007 Nov 04; 60(5):1051-9. PubMed ID: 17848374 [Abstract] [Full Text] [Related]
19. Genomic diversity of two lineages of exfoliative toxin A-converting phages predominating in Staphylococcus aureus strains in the Czech Republic. Holochová P, Růzicková V, Pantůcek R, Petrás P, Janisch R, Doskar J. Res Microbiol; 2010 May 04; 161(4):260-7. PubMed ID: 20382218 [Abstract] [Full Text] [Related]
20. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R. Clin Infect Dis; 2006 Oct 15; 43(8):971-8. PubMed ID: 16983607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]